To address this issue, we showed that recombinant periostin induced severe colitis in DSS-treated Postn-/- mice, and periostin nAb reduced colitis in DSS-treated wild-type mice, suggesting that periostin could be an effective therapeutic target for IBD. The gene discussed is POSTN; the disease is colitis.